Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Aldevron
Aldevron
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Aldevron launches CRISPR RNP manufacturing service
The platform is designed to deliver a clinical grade RNP complex generated from a CRISPR nuclease and guide RNA (gRNA)
Manufacturing
PE firm acquires Aldevron
The CDMO from North Dakota has additional operations in Madison, Wisconsin, and Freiburg, Germany
Design & Build
Aldevron to build gene therapy campus at US headquarters
The nearly 0.5 million sqft facility in Fargo could employ 1,000 people when fully operational in 2021
Design & Build
Aldevron announces German antibody facility expansion
Expansion plans by the US-based CMO include 4,300 sqft of laboratory and production space
Subscribe now